AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2022
Sep 12, 2022
35599_dirs_2022-09-12_b1faec6f-c200-45e3-ad26-921b1871deaf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2022-09-09
Reporting Person: Raykov Rosty (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-09-09 | Commons Shares | $0.72 | M | 16666 | Acquired | 2023-08-23 | options (16666) | Direct |
Footnotes
F1: 1. Represents options granted on August 23, 2013, with a $0.72 USD strike price and an expiration of August 23, 2023.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20